(Back to Case Studies)

Case Study: Increased Hematocrit with Prohemia® maintained after 6 Months

Prohemia® case study shows maintained blood building effects at six months in a 42-year-old male with anemia.

METHODS: A 42-year-old male with anemia agreed to participate in a case study to help demonstrate the efficacy of Prohemia® to support healthy blood levels for a sustained period of time. Four (4) Prohemia® capsules were ingested daily for six (6) months. Hematocrit and hemoglobin levels were measured after six months of continuous Prohemia® use.

RESULTS: Following use of Prohemia®, the subject’s hematocrit and hemoglobin improved to near healthy normal levels. These improvements were maintained over a six month period.

 

Hemoglobin
(grams/dL)

Hematocrit
(%)

Before Prohemia®

12.0
(anemic)

35.2
(anemic)

After Prohemia®

13.3
(near normal)

39.9
(near normal)

CONCLUSION:  Although limited to a single subject, this anemic subject showed sustained improvements in blood levels following six (6) months of Prohemia® use.  Specifically, hemoglobin levels increased 11% and hematocrit increased 13%.  This anemic subject’s blood levels returned to near healthy normal levels after two months of Prohemia® use.  This case study also agrees with previous published clinical studies that showed potent increases in erythropoietin (EPO) levels following ingestion of the ingredients found in Prohemia®.

*Results may vary and the case study results cannot be expected in 100% of Prohemia users.